Director/PDMR Shareholding

RNS Number : 1883A

Nuformix PLC

31 January 2022

 

31 January 2022

Nuformix plc

("Nuformix" or the "the Company")

Director/PDMR Shareholding

Nuformix plc  (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that it has granted a total of 3,000,000 warrants each to Dr Alastair Riddell, Dr Julian Gilbert and Maddy Kennedy with an exercise price of 1.45p per share.

- Ends -

  Enquiries:

Nuformix plc			via Walbrook
Dr Alastair Riddell, Executive Chairman
Allenby Capital Limited			[phone]
Nick Athanas / George Payne (Corporate Finance)
Stefano Aquilino / Matt Butlin (Sales and Corporate Broking)
Walbrook PR	[e-mail]  or [phone]
Anna Dunphy / Phillip Marriage		Tel: [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Alastair Riddell
2	Reason for the notification
a)	Position/status	PDMR - Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Nuformix plc
b)	LEI	2138003XG3H3I2J3BJ24
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Warrants to acquire ordinary shares at a price of 1.45p per share. GB00BYW79Y38
b)	Nature of the transaction	Granting of warrants
c)	Price(s) and volume(s)	Price(s) Volume(s) 0 3,000,000
d)	Aggregated information	Single Transaction
e)	Date of the transaction	31 January 2022
f)	Place of the transaction	Off-market transaction

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Julian Gilbert
2	Reason for the notification
a)	Position/status	PDMR - Non-executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Nuformix plc
b)	LEI	2138003XG3H3I2J3BJ24
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Warrants to acquire ordinary shares at a price of 1.45p per share. GB00BYW79Y38
b)	Nature of the transaction	Issue of warrants
c)	Price(s) and volume(s)	Price(s) Volume(s) 0 3,000,000
d)	Aggregated information	Single Transaction
e)	Date of the transaction	31 January 2022
f)	Place of the transaction	Off-market transaction

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Maddy Kennedy
2	Reason for the notification
a)	Position/status	PDMR - Non-executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Nuformix plc
b)	LEI	2138003XG3H3I2J3BJ24
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Warrants to acquire ordinary shares at a price of 1.45p per share. GB00BYW79Y38
b)	Nature of the transaction	Issue of Warrants
c)	Price(s) and volume(s)	Price(s) Volume(s) 0 3,000,000
d)	Aggregated information	Single Transaction
e)	Date of the transaction	31 January 2022
f)	Place of the transaction	Off-market transaction

 

END

 

 

DSHWPUMUGUPPGCG